[Frontiers in Bioscience 2, d401-416, August 15, 1997]

	[Frontiers in Bioscience 2, d401-416, August 15, 1997] Reprints PubMed CAVEAT LECTOR
	NATURAL IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUSES: PROSPECTS FOR AIDS VACCINES Omar Bagasra and Muhammad Amjad The Dorrance H. Hamilton Laboratories, Section of Molecular Retrovirology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical Collage, Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Suite 329, Philadelphia, PA 19107 Received 6/18/97, Accepted 7/22/97 16. REFERENCES 1. Clerici, M. Giorgi, J.V. Chou, C.C. Gudeman, V. K. Zack, J. A. Gupta, P. & H. N. Ho: Cell mediated immune response to HIV-1 in seronegative homosexuals with recent sexual exposure to HIV-1. J Infect Diseases 165, 1012-19 (1992). 2. Rowland-Jones, S. Sutton, J. Ariyoshi, K. Dong, T. Gotch, F. McAdam, S. Whitby, D. Sabally, S. Gallimore, A. & T. S. Corrah: HIV-specific cytotoxic T-cell in HIV-exposed but uninfected Gambiae women. Nature Med 1, 59-64 (1995). 3. Langlade-Demoyen, P. Ngo-Giang-Huong, N. Ferchal, F. & E. Oksenhendler: Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-1 infected patients. J Clin Invest 93, 1293-1297 (1994). 4. Liu, R. Paxton, W. A. Choe, S. Ceradini, D. Martin, S. R. Horuk, R. MacDonald, M. E. Stuhlmann, H. Koup, R. A. & N. R. Landau: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996). 5. Cocchi, F. DeVico, A. L. Garzino-Demo, A. Arya, S. K. Gallo, R. C. & P. Lusso: Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV suppressive factors produced by CD8+ T cells. Science 270, 1811-15 (1995). 6. Choe, H. Farzan, M. Sun, Y. Sullivan, N. Rollins, B. Ponath, P. D. Wu, L. Mackay, C. R. LaRosa, G. Newman, W. Gerard, N. Gerard, C. & J. Sodroski: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996). 7. Alkhatib, G. Combadiere, C. Broder, C.C. Feng, Y. Kennedy, P. E. Murphy, P. M. & E. A. Berger: CC CKR5: A RANTES, MIP-1alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996). 8. Samson, M. Libert, F. Doranz, B. J. Rucker, J. Liesnard, C. Farber, C. M. Saragosti, S. Lapoumeroulie, C. Cognaux, J. Forceille, C. Muyldermans, G. Verhofstede, C. Burtonboy, G. Georges, M. Imai, T. Rana, S. Yi, Y. Smyth, R. J. Collman, R. G. Doms, R. W. Vassart, G. & M. Parmentier: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of CCR5 chemokine receptor gene. Nature 382, 722-725 (1996) 9. Dean, M. Carrington, M. & C. Winkler: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862 (1996). 10. CDC Report. Persistent lack of detectable HIV-1 antibody in a person with HIV infection. MMWR 45(9)181-295 (1996). 11. Alastair, J. & J. Wood: Management of occupational exposure to blood-borne viruses. New Eng J Med 332, 443-450 (1995). 12. Marcus, R: Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. New Eng J Med 319, 1118-1122 (1988). 13. Detels, R. Liu, Z. Hennessey, K. Kan, J. Visscher, B. R. Taylor, J. M. Hoover, D. R. Rinaldo, C. R. Jr. Phair, J. P. & A. J. Saah: Resistance to HIV-1 infection. J AIDS 7, 1263-1269 (1994). 14. DeGruttola, V. Seage, G. R. 3d. Mayer, K. H. C. R. Horsburgh Jr.: Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 42, 849-856 (1989). 15. Prevots, D. R., Ancelle-Park, R. A. & A. A. Neal: The epidemiology of heterosexually acquired HIV infection and AIDS in Western industrialized countries. AIDS 8, S109-S117 (1994). 16. Taylor, R: Quiet clues to HIV-1 immunity : do some people resist infection? J. NIH Res 6, 29-31 (1994). 17. Walker, C. M. . Moody, D. J. Stites, D. P. & J. A. Levy : CD8-positive T lymphocytes control of HIV replication in cultured CD4-positive cells varies among infected individuals. Cell Immunol 199, 470-475 (1989). 18. Walker, C. M. Erickson, A. L. Hsueh, F. C. & J. A. Levy: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells involves a non-cytotoxic mechanism. J Virology 65, 5921-5927 (1991). 19. Bagasra, O. Whittle, P. & R. J. Pomerantz: The role of CD8+ lymphocytes on unstimulated peripheral blood lymphocytes to infection with HIV-1. Immunol Letters 35, 83-92 (1993). 20. Kannagi, M. Chalifoux, L. V. & C. I. Lord: Suppression of simian immuno-deficiency virus replication in vitro by CD8-positive lymphocytes. J Immunol 140, 2237-2242 (1988). 21. Kannagi, M. Masuda, T. Hattori, T. Kanoh, T. Nasu, K. Yamamoto, N. & S. Harada: Interference with human immunodeficiency virus (HIV) replication by CD8+T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Virology 64, 3799-3805 (1990). 22. Brinchmann, J. E. Gaudernack, G. & F. Vartdal: CD8+ T -cells inhibit HIV-1 replication in naturally infected CD4+T cells: Evidence for a soluble inhibitor. J Immunol 144, 2961-2966 (1990). 23. Walker, C. M. & J. A. Levy: A diffusible lymphokine produced by CD8-positive T lymphocytes suppresses HIV replication. Immunology 66 628-630 (1989). 24. Walker, C. M. Thomson-Honnebier, G. A. Hsueh, F. C. Erickson, A. L. Pan, L. Z. & J. A. Levy: CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 137, 420-428 (1991). 25. J. M. Coffin : Retoviridae: The viruses and their replication. In: Fields Virology, Chapter 58, pp 1767-1847 Lippincott-Raven, Philadelphia (1996). 26 Montelaro, R. C: Vaccines against retroviruses. In " The Retroviridae" vol. 4, Ed: Levy J. A, 605-653, Plenum Press, New York (1995). 27. Hoth, D. F. Bolognesi, D. P. Corey, L. & S. H. Vermund: HIV Vaccine development: A progress report. Ann Int Med 8, 603-611 (1994). 28. Pomerantz, R. J. & D. Trono: Genetic therapies for HIV infections: promise for. the future. AIDS 9, 985-993 (1995). 29. Wei, X. Ghosh, S. K. Taylor, M. E. Johnson, V. A Emini, E. A. Deutsch, P. Lifson, J. D. Bonhoeffer, S. Nowak, M. A. & B. H. Hahn : Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-126 (1995). 30. Fauci, A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239, 617-620 (1988). 31. Bagasra, O. Farzadegan, H. Seshamma, T. Oakes, J. W. Saah, A. & R. J. Pomerantz: Detection of human immunodeficiency virus type 1 in mononuclear cells by in situ polymerase chain reaction. New Eng J Med 326,1385-1391(1992). 32. Bagasra, O. & R. J. Pomerantz: HIV-1 provirus is demonstrated in peripheral blood monocytes in vivo: A study utilizing an in situ PCR. AIDS Res Hum Retroviruses 9:69-76, 1993 33. Patterson, B. K. Till, M. Otto, P. Goolsby, C. Furtado, M. R. McBride, L. J. & S. M. Wolinsky: Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260, 976-980 (1993). 34. Embretson, J. Zupancic, M. Beneke, J. Till, M. Wolinsky, S. Ribas, J. L. Burke, A. & A. T. Haase: Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci USA. 90, 357-361 (1993). 35. Embretson, J. Zupancic, M. Ribas, J. L. Burke, A. Racz, P. Tenner-Racz, K. & A. T. Haase: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-62 (1993). 36. Pantaleo, G. Graziosi, C. Demarest, J. F. Cohen, O. J. Vaccarezza, M. Gantt, K. Muro-Cacho, C. & A. S. Fauci : HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-8 (1993). 37. Jeng, C. R. English, R. V. Childers, T. Tompkins, M. B. & W. A. Tompkins: Evidence for CD8+ antiviral activity in cats infected with Feline immunodeficiency virus. J Virol 2474-2480 (1996). 38. Putkonen, P. Walther, L. Zhang, Y. J. Li, S. L. Nilsson, C. Albert, J. Biberfeld, P. Thorstensson, R. & G. Biberfeld: Long-term protection against SIV-induced disease in macaque vaccinated with a live attenuated HIV-2 vaccine. Nature Med 1, 914-918 (1995). 39. Travers, K. Mboup, S. Marlink, R. Gueye-Nidaye, A. Siby, T. Thior, I. Traore, I. Dieng-Sarr, A. Sankale, J. L. & C. Mullins : Natural protection against HIV-1 infection provided by HIV-2. Science 268,1612-15 (1995). 40. Bonhoeffer, S. & M. Nowak: Can live attenuated virus work as post-exposure treatment. Immunol Today 16, 131-34 (1995). 41. Baba, T. W. Gong, Y. S. Pennick, D. Bronson, R. Greene, M. F. & R. M. Ruprecht: Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-25 (1995). 42. Shibata, R. Seimon, C. Cho, M. W. Arthur, L. O. Nigida, S. M. Jr. Matthews. T.Sawyer, L. A. Schultz, A. Murthy, K. K. Israel, Z. Javadian, A. Frost, P.Kennedy, R. C. Lane, H. C. & M. A. Martin: Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of HIV-1. J Virol 70(7), 4361-69 (1996). 43. Putkonen, P. Thorstensson, R. Albert, J. Hild, K. Norrby, E. Biberfeld, P. & G. Biberfeld: Infection of cynomolgus monkey with HIV-2 protects against protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 4, 783-789 (1990). 44. Doranz, B. J. Rucker, J. Yi, Y. Smyth, R. J. Samson, M. Peiper, S. C. Parmentier, M. Collman, R. G. & R. W. Doms: A dual tropic primary HIV-1 isolate that uses Fusin and beta-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996). 45. Dragic, T. Litwin, V. Allaway, G. P. Martin, S. R. Huang, Y. Nagashima, K. A. Cayanan, C. Maddon, P. J. Koup, R. A. Moore, J. P. & W. A. Paxton: HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 667-673 (1996). 46. Feng, Y. Broder, C.C. Kennedy, P. E. & E. A. Berger : HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272, 872-877 (1996). 47. Neote, K. DiGregorio, D. Mak, J. Y. Horuk, R. & T. J. Schall: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72, 415-425 (1993). 48. Siegel, F. Kurth, R. & S. Norley: Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host. J AIDS 8, 217-26 (1995). 49. Gardner, M. Rosenthal, A. Jennings, M. Yee, J. Antipa, L. & E. Robinson Jr: Passive immunization of Rhesus macaques against SIV infection and disease: Partial protection with plasma from vaccinated monkey and possible enhancement with plasma from healthy carrier, AIDS Res Hum Retroviruses 11,(7), 843-54 (1995). 50. Girard, M. P. & J. W. Eichberg: Progress in the development of SIV vaccines. AIDS 4, S143 (1990). 51. Karzon, D. T. Bolognesi, D. P. & W. C. Koff: Development of a vaccine for the prevention of AIDS, a critical appraisal. Vaccine 10, 1039 (1992). 52. Kent, K. A. Kitchin, P. Mills, K. H. Page, M. Taffs, F. Corcoran, T. Silvera, P. Flanagan, B. Powell, C. & J. Rose: Passive immunization of cynomolgus macaque with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Res Hum Retroviruses 10,189-194 (1994). 53. Orentas, R. J. Hildreth, J. E. Obah, E. Polydefkis, M. Smith, G. E. Clements, M. L. & R. F. Siliciano: Induction of CD4+ human cytolytic T cell-specific for HlV-infected cell by a gpl60 subunit vaccine. Science 248, 1234 (1990). 54. Ruprecht, R. M. Mullaney, S. Bernard, L. D. GamaSosa, M. A. Hom, R. C. & R. W. Finberg : Vaccination with a live retrovirus: The nature of the protective immune response. Proc Natl Acad Sci USA 87, 5558-62 (1990). 55. Alter, H. J. Eichberg, J. W. Masur, H. Saxinger, W. C. Gallo, R. Macher, A.M. Lane, H. C. & A. S. Fauci : Transmission of HTLV-III infection from human plasma to chimpanzees an animal model of AID. Science 226, 549-52 (1984). 56. Francis, D. P. Feorino, P.M. Broderson, J. R. McClure, H. M. Getchell, J. P. McGrath, C. R. Swenson, B. McDougal, J. S. Palmer, E. L. & A. K. Harrison: Infection of chimpanzees with lymphadenopathy associated virus. Lancet 2,1276-7(1984). 57. Berman, P. W. Gregory, T. Crase, D. & L. A. Lasky: Protection of chimpanzees from infection by HlV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. Nature 345, 622-625 (1990). 58. Heeney, J. Jonker, R. Koornstra, W. Dubbes, R. Niphuis, H. DiRienzo, A. M. Gougeon, M. L. & L. Montagnier: The resistance of HlV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 22, 194-200 (1993). 59. Eichberg, J. W. Zarling, J. M. Alter, H. J. Levy, J. A. Berman, P. W. Gregory, T. Lasky, L. A. McClure, J. Cobb, K. E. & P. A. Moran: T-cell responses to human Immunodeficiency virus (HIV) and its recombinant antigens in HIV- infected chimpanzees. J Virol 61, 3804-8 (1987). 60. Berman, P.W. Eastman, D. J. Wilkes, D. M. Nakamura, G. R. Gregory, T. J. Schwartz, D. Gorse, G. Belshe, R. Clements, M. L. & R. A. Byrn: Comparison of the immune response to recombinant gp120 in humans and chimpanzees. AIDS 8, (5) 591-601 (1994). 61. Girard, M. Kieny, M. P. Pinter, A. Barre-Sinoussi, F. Nara, P. Kolbe, H. Kusumi, K. Chaput, A. Reinhart, T. & E. Muchmore: Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88, 542-546 (1991). 62. Moore, J. P. Cao, Y. Leu, J. Qin, L. Korber, B. & D. D. Ho: Inter and intraclade neutralization of human immunodeficiency virus type 1: genetic clads do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virology 70, 427-444 (1996). 63. Trkola, A. Pomales, A.B. Yuan, H. Korber, B. Maddon, P.J. Allaway, G.P. Katinger, H. Barbas, C.F 3rd. Burton, D.R. & D. D. Ho: Cross-clad neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virology 69,1586-96 (1995). 64. Girard, M.: Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virology 70, 8229-33 (1996). 65. Mascola, J. R. Mathieson, B. J. Zack, P. M. Walker, M. C. Halstead, S. B. & D. S. Burke: Summary Report: Workshop on potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res and Human Retroviruses. 9, 1175-84 (1993). 66. Salk, J. Bretscher, P. A. Salk, P. L. Clerici, M. & G. M. Shearer: A strategy for prophylactic vaccination against HIV. Science 260,1270-72 (1993). 67. Clerici, M. & G. M.Shearer: A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14, 107-111(1993). 68. Romagnani, S. Del Prete, G. Manetti, R. Ravina, A. Annunziato, F. De Carli, M. Mazzetti, M. Piccinni, M. P. D'Elios, M. M. & P. Parronchi: Role of Th1/Th2 cytokines in HIV infection. Immun Rev 140, 73-94 (1994 ). 69. Phillips, A. N: Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271, 497-499 (1996). 70. Matteucci, D. Pistello, M. Mazzetti, P. Giannecchini, S. Del Mauro, D. Zaccaro, L. Bandecchi, P. Tozzini, F. & M. Bendinelli: Vaccination protects against in vivo-grown feline immunofecifiency virus even in the absence of detectable neutralization antibodies. J Virology 70, 617-622 (1996). 71. SanMiguel, P. Tikhonov, A. Jin, Y. K. Motchoulskaia, N. Zakharov, D. Melake-Berhan, A. Springer, P.S. Edwards, K.J. Lee, M. Avramova, Z. & J. L. Bennetzen: Nested retrotransposons in the intergenic regions of the maize genome. Science 274, 765-768 (1996). 72. Martin, M. A. Bryan, T. Rasheed, S. & A. S. Khan: Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci USA 78,4892-4899 (1981). 73. Horwitz, M.S. Boyce-Jacino, M.T. & A. J. Faras : Novel human endogenous sequences related to human immunodeficiency virus type 1. J Virol 66, 2170-2179 (1992). 74. Koup, R. A. Safrit, J. T. Cao, Y. Andrews, C. A. McLeod, G. Borkowsky, W. Farthing, C. & D. D. Ho: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68, 4650-55 (1994). 75. Luzuriaga, K. McQuilken, P. Alimenti, A. Somasundaran, M. Hesselton, R. & J. L. Sullivan, J.L: Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Diseases 167, 1008-13 (1993). 76. Jurriaana, S. Van Gemen, B. Weverling, G.J. Van Strijp, D. Nara, P. Coutinho, R. Koot, M. Schuitemaker, H. & J. Goudsmit: The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course. J Clin Invest 204, 223-233 (1994). 77. Borrow, P. Lewicki, H. Wei, X. Horwitz, M. S. Peffer, N. Meyers, H. Nelson, J. A. Gairin, JE. Hahn, B.H. Oldstone, M.B. & G. M. Shaw : Virus specific CD8+ cytotoxic T-lymphocytes activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68, 6103-6110 (1994). 78. Wainberg, M.A, Blain, N. & L. Fitz-Gibbon: Differential susceptibility of human lymphocyte cultures to infection by HIV. Clin Exp Immunol 136-142 (1987). 79. Spira, A. & D.D.Ho: Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J Virology 69, 422-429 (1995). 80. Pan, L. Z. Sheppard, H. W. Winkelstein, W. & J. A. Levy: Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection. J Infect Dis 164, 962-4 (1991). 81. Soriano, V. & I. Hewlett: Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain. Lancet 335, 860 (1990). 82 Rowland-Jones, S. Sutton, J. Ariyoshi, K. Dong, T. Gotch, F. McAdam, S. Whitby, D. Sabally, S. Gallimore, A. & T. Corrah: HIV-1-specific cytotoxic T-cell in an HIV-exposed but uninfected infant. Lancet 341, 860-861 (1995). Nature Med 1(1), 59-64 (1995). 83 Deacon, N.J. Tsykin, A. Solomon, A. Smith, K. Ludford-Menting, M. Hooker, D.J. McPhee, D.A. Greenway, A.L. Ellett, A. & C. Chatfield: Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-91 (1995). 84. Bryson, Y. J. Pang, S. Wei, L. S. Dickover, R. Diagne, A. & I. S. Chen: Clearance of HIV infection in a perinatally infected infant. New Engl J Med 332, 833-838 (1995). 85. Roques, P.A. Gras, G. Parnet-Mathieu, F. Mabondzo, A.M. Dollfus, C. Narwa, R. Marce, D. Tranchot-Diallo, J. Herve, F. & G. Lasfargues: Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 9: F19-F26 (1995). 86. Baur, A. Schwarz, N. Ellinger, S. Korn, K. Harrer, T. Mang, K. & G. Jahn: Continuous clearance of HIV in a vertically infected child. Lancet 2, 1045 (1989). 87. Kestler, H.W.3rd. Ringler, D.J. Mori, K. Panicali, D.L. Sehgal, P.K. Daniel, M.D. & R. C. Desrosiers: Importance of the nef gene for maintenance of high virus loads and/or development of AIDS. Cell 65, 651-62 (1991). 88. Huang, Y., Zhang, L. & D. D. Ho: Characterization of nef sequences in long term survivors of human immunodeficiency virus type 1 infection. J Virol 69, 93-100 (1995). 89. Saksela, K. Stevens, C. E. Rubinstein, P. Taylor, P. E. & D. Baltimore: Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci USA 91:1104-8 (1994). 90. Bagnarelli, P. Menzo, S. Valenza, A. Manzin, A. Giacca, M. Ancarani, F. Scalise, G. Varaldo, P. E. & M. Clementi: Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol 66:7328-35 (1992). 91. Almond, N. Kent, K. Cranage, M. Rud, E. Clarke, B. & E. J. Stott: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345,1342-1344 (1995). 92. Clements, J. E. Montelaro, R. C. Zink, M. C. Amedee, A.M. Miller, S. Trichel, A.M. Jagerski, B. Hauer, D. Martin, L. N. & R. P. Bohm: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus J Virology 69, 2737-2744 (1995). 93. Daniel, M. D. Kirchhoff, F. Czajak, S. C. Sehgal, P.K.. & R. C. Desrosiers: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941 (1992). 94. Fultz, P.N. Nara, P. Barre-Sinoussi, F. Chaput, A. Greenberg, M. L. Muchmore E. Kieny, M. P. & M. Girard: Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256, 1687-1690, (1992). 95. Heeney, J. L. Holterman, L. ten Haaft, P. Dubbes, R. Koornstra, W. Teeuwsen, V. Bourquin, P. Norley, S. & H. Niphuis: Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Human Retroviruses 10 (suppl) S117-S121 (1994). 96. Hirsch, V. M. Dapolito, G. A. Goldstein, S. McClure, H. Emau, P. Fultz, P.N. Isahakia, M. Lenroot, R. Myers, G. & P. R. Johnson : A distinct African lentivirus from Sykes' monkeys. J Virol 67, 1517-1528 (1993). 97. Muller, M. C. Saksena, N. K. Nerrienet, E. Chappey, C. Herve, V. M. Durand, J. P. Legal-Campodonico, P. Lang, M. C. Digoutte, J. P. & A. J. Georges: Simian immunodeficiency viruses from Central and Western Africa: Evidence for a new species-specific lentivirus in Tantalus monkeys. J Virol 67, 1227-1235 (1993). 98. Ohta, Y. Masuda, T. Tsujimoto, H. Ishikawa, K. Kodama, T. Morikawa, S. Nakai, M. Honjo, S. & M. Hayami : Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non human primates. Int J Cancer 41, 115-122 (1988). 99. Fultz, P.N. McClure, H. M. Anderson, D. C. Swenson, R. B. Anand, R. & A. Srinivasan: Isolation of a T-lymphocyte retrovirus from naturally infected sooty mangabey monkeys. Proc Natl Acad Sci USA 83, 5286-5290 (1989). 100. Gao, F. Yue, L. White, A. T. Pappas, P. G. Barchue, J. Hanson, A. P. Greene, B. M.Sharp, P.M. Shaw, G. M. & B. H. : Human infection by genetically diverse SlVsm-related HIV-2 in West Africa. Nature 358, 495-499 (1992). 101. Huet, T. Cheynier, R. Meyerhans, Roelants, A. G. & S. Wain-Hobson : Genetic organization of a chimpanzee lentivirus related to HIV-I. Nature 345, 356-358 (1994). 102. Peeters, M. Honore C. Huet T. Bedjabaga L. Ossari S. Bussi P. Cooper R. W. & E. Delaporte: Isolation and partial characterization of an HlV-related virus occurring naturally in chimpanzees in Gabon. AIDS 3, 625- 630 (1989). 103. Francis, D. Ferino, P. Broderson, J. McClure, H. Getchell, J. McCrath, C. Swenson, B. McDougal, J. Palmer, E. Harrison, A. Barre-Sinoussi, F. Chermann, J-C. Montagnier, L. Curran, J. Cabradilla, C. & V. Kalyanaraman: Infection of chimpanzees with lymphadenopathy-associated virus. Lancet ii, 127G-1277 (1984). 104. Gadjusek, D. Gibbs, C. Rodgers-Johnson, P. Amyx, H. Asher, D. Epstein, L. Sarin, P. Gallo, R. Maluish, A. Arthru, L, Montagnier, L. & D. Mildvan: Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissue from AIDS patients. Lancet i, 55-56 (1985). 105. Nara, P. Hatch, W. Kessler, J. & S. Carter: The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J. Med. Primatol. 18, 343-55 (1989). 106. Eichberg, J. W. Zarling, J. M. Alter, H. J. Levy, J. A. Berman, P. W. Gregory, T. Lasky, L. A. McClure, J. Cobb, K. E. & P. A. Moran: T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. J Virol 61, 3804-3808 (1987 ). 107. Zarling, J. Alter, H. J. Eichberg, J. W. Fauci, A. S., Robey, W. G. & R. C. Gallo: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J Immunol 139, 988-990 (1987). 108. Weiss, R. A : Foamy retroviruses: A virus in search of a disease. Nature 333, 497-498 (1988). 109. Mergia, A. & P. A. Luciw: Replication and regulation of primate foamy viruses. Virology 184, 475-482 (1991). 110. K. Sugamura & Y. Hinuma: Human retroviruses: HTLV-I and HTLV-II. In: The Retroviridae. Ed: Levy J. A. p399-435, Plenum Press, New York and London (1992). 111. Utz, U. Banks, D. Jacobson, S. & W. E. Biddison: Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: Evidence of oligoclonal expansion. J Virol 70, 843-851 (1996). 112. Kestens, L. Vingerhoets, J. Peeters, M. Vanham , G. Vereecken , C. Penne, G. Niphuis, H. van Eerd, P. van der Groen, G. & P. Gigase: Phenotypic and functional parameters of cellular immunity in chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Inf Dis 172, 957-63 (1995). 113. Copeland, K. F. McKay, P. J. & K. L. Rosenthal: Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T cells is dependent on the NFAT-1 element. AIDS RES & Human Retroviruses 12, 143-147 (1996). 114. Bouscarat, F. Descamps, V. Cadot, B. & S. Belaich: Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res & Human Retroviruses 12, 17-24 (1996). 115. Yasutomi, Y. Reimann, K. A. Lord, C. I. Miller, M. D. & N. L. Letvin: Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected Rhesus monkeys. J Virol 67, 1707-11 (1993). 116. Sonza, S. Maerz, A. Deacon, N. Meanger, J. Mills, J. & S. Crowe: Human immunodeficiency virus type-1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 70(6), 3863-3869 (1996). 117. Paxton, W. A. Martin, S. R. Tse, D. O'Brien, T. R. Skurnick, J. VanDevanter, N. L. Padian, N. Braun, J. F. Kotler, D. P. Wolinsky, S. M. & R. A. Koup: Relative resistance to HIV-1 infection of CD4 lymphocytes from person who remain uninfected despite multiple high-risk sexual exposure. Nature Med 2, 412-417 (1996). 118. O. Bagasra, & R. J. Pomerantz: Do alcohol and other substance of abuse alter the natural evolution of and the susceptibility to human immunodeficiency virus type-1 infection? In: "Alcohol, Drugs of abuse, and Immune Function" Ed: Watson, R. CRC Press Inc, New York, (1995). 119. Avins, A. L. Woods, W. J. Lindan, C. P. Hudes, E. S. Clark, W. & S. B. Hulley: HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 7, 515-18 (1994). 120. Fong, I. W. Read, S. Wainberg, M. A. Chia, W. K. & C. Major: Alcoholism and rapid progression to AIDS after seroconversion. Clin Infect Dis 19, 337-8, 1994 121. Mahler, J. Yi, D. & M. Sacks: Undetected HIV infection among patients admitted to an alcohol rehabilitation unit. Am J Psychiatry 151, 439-40 (1994). 122. Bagasra, O. Kajdacsy-Balla, A. & H. W. Lischner: Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV-1 and on selected T-cell functions. Alcoholism: Clin & Expt Res 13, 636-43 (1987). 123. Bagasra, O. Kajdacsy-Balla, A. Lischner, H. W. & R. J. Pomerantz: Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Diseases 16, 789-97 (1993). 124. Bagasra, O. & R. J. Pomerantz: Increased HIV-1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Diseases 168, 1157-64 (1993). 125. Peterson, P. K. Sharp, B. M. Gekker, G. Portoghese, P. S. Sannerud, K. & H. H. Balfour, Jr.: Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell co-cultures. AIDS 4, 869-73 (1990). 126. Chaisson, R. E. Bacchetti, P. Osmond, D. Brodie, B. Sande, M. A. & A. R. Moss: Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261, 561-51 (1989). 127. Watson, E. S. Murphy, J. C. ElSohly, H. N. ElSohly, M. A. & C. E. Turner: Effects of the administration of coca alkaloids on the primary immune response of mice: interaction with delta-9-tetrahydrocannabinol and ethanol. Toxicol Appl Pharmacol 71,1-16 (1983). 128. Kirchhoff, F. Greenough, T. C. Brettler, D. B. Sullivan, J. L. & R. C. Desrosiers: Brief report: Absence of intact nef sequences in a long term survivor with non progressive HIV-1 infection. N Engl J Med 332, 228-32 (1995). 129. Zack, J. A: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile latent virus structure. Cell 61, 215-222 (1990). 130. Bukrinsky, M. I. Stanwick, T. L. Dempsey, M. P. & M. Stevenson: Quiescent T-lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427 (1991). 131. Barker, E. Mackewicz, C. E. & J. A. Levy: Effects of Th1 and Th2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 92,11135-39 (1995). 132. Bagasra, O. Howeedy, A. & R. J. Pomerantz: Functional analysis of T-cell subsets in chronic alcoholism. Immunology 61, 63-9 (1987). 133. Bagasra, O. Bachman, S. E. Jew, L. Tawadros, R. Cater, J. Boden, G. Ryan, I. & R. J. Pomerantz: Increased HIV-1 replication in human peripheral blood mononuclear cells induced by ethanol: Potential immuno-pathologic mechanisms. J Infect Diseases 173, 550-558 (1996).

[Frontiers in Bioscience 2, d401-416, August 15, 1997]
Reprints
PubMed
CAVEAT LECTOR

NATURAL IMMUNITY AGAINST HUMAN IMMUNODEFICIENCY VIRUSES: PROSPECTS FOR AIDS VACCINES
Omar Bagasra and Muhammad Amjad
The Dorrance H. Hamilton Laboratories, Section of Molecular Retrovirology, Division of Infectious Diseases, Department of Medicine, Jefferson Medical Collage, Thomas Jefferson University, Jefferson Alumni Hall, 1020 Locust Street, Suite 329, Philadelphia, PA 19107

Received 6/18/97, Accepted 7/22/97

16. REFERENCES

1. Clerici, M. Giorgi, J.V. Chou, C.C. Gudeman, V. K. Zack, J. A. Gupta, P. & H. N. Ho: Cell mediated immune response to HIV-1 in seronegative homosexuals with recent sexual exposure to HIV-1. J Infect Diseases 165, 1012-19 (1992).

2. Rowland-Jones, S. Sutton, J. Ariyoshi, K. Dong, T. Gotch, F. McAdam, S. Whitby, D. Sabally, S. Gallimore, A. & T. S. Corrah: HIV-specific cytotoxic T-cell in HIV-exposed but uninfected Gambiae women. Nature Med 1, 59-64 (1995).

3. Langlade-Demoyen, P. Ngo-Giang-Huong, N. Ferchal, F. & E. Oksenhendler: Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-1 infected patients. J Clin Invest 93, 1293-1297 (1994).

4. Liu, R. Paxton, W. A. Choe, S. Ceradini, D. Martin, S. R. Horuk, R. MacDonald, M. E. Stuhlmann, H. Koup, R. A. & N. R. Landau: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377 (1996).

5. Cocchi, F. DeVico, A. L. Garzino-Demo, A. Arya, S. K. Gallo, R. C. & P. Lusso: Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV suppressive factors produced by CD8+ T cells. Science 270, 1811-15 (1995).

6. Choe, H. Farzan, M. Sun, Y. Sullivan, N. Rollins, B. Ponath, P. D. Wu, L. Mackay, C. R. LaRosa, G. Newman, W. Gerard, N. Gerard, C. & J. Sodroski: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148 (1996).

7. Alkhatib, G. Combadiere, C. Broder, C.C. Feng, Y. Kennedy, P. E. Murphy, P. M. & E. A. Berger: CC CKR5: A RANTES, MIP-1alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958 (1996).

8. Samson, M. Libert, F. Doranz, B. J. Rucker, J. Liesnard, C. Farber, C. M. Saragosti, S. Lapoumeroulie, C. Cognaux, J. Forceille, C. Muyldermans, G. Verhofstede, C. Burtonboy, G. Georges, M. Imai, T. Rana, S. Yi, Y. Smyth, R. J. Collman, R. G. Doms, R. W. Vassart, G. & M. Parmentier: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of CCR5 chemokine receptor gene. Nature 382, 722-725 (1996)

9. Dean, M. Carrington, M. & C. Winkler: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862 (1996).

10. CDC Report. Persistent lack of detectable HIV-1 antibody in a person with HIV infection. MMWR 45(9)181-295 (1996).

11. Alastair, J. & J. Wood: Management of occupational exposure to blood-borne viruses. New Eng J Med 332, 443-450 (1995).

12. Marcus, R: Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. New Eng J Med 319, 1118-1122 (1988).

13. Detels, R. Liu, Z. Hennessey, K. Kan, J. Visscher, B. R. Taylor, J. M. Hoover, D. R. Rinaldo, C. R. Jr. Phair, J. P. & A. J. Saah: Resistance to HIV-1 infection. J AIDS 7, 1263-1269 (1994).

14. DeGruttola, V. Seage, G. R. 3d. Mayer, K. H. C. R. Horsburgh Jr.: Infectiousness of HIV between male homosexual partners. J Clin Epidemiol 42, 849-856 (1989).

15. Prevots, D. R., Ancelle-Park, R. A. & A. A. Neal: The epidemiology of heterosexually acquired HIV infection and AIDS in Western industrialized countries. AIDS 8, S109-S117 (1994).

16. Taylor, R: Quiet clues to HIV-1 immunity : do some people resist infection? J. NIH Res 6, 29-31 (1994).

17. Walker, C. M. . Moody, D. J. Stites, D. P. & J. A. Levy : CD8-positive T lymphocytes control of HIV replication in cultured CD4-positive cells varies among infected individuals. Cell Immunol 199, 470-475 (1989).

18. Walker, C. M. Erickson, A. L. Hsueh, F. C. & J. A. Levy: Inhibition of human immunodeficiency virus replication in acutely infected CD4+ cells involves a non-cytotoxic mechanism. J Virology 65, 5921-5927 (1991).

19. Bagasra, O. Whittle, P. & R. J. Pomerantz: The role of CD8+ lymphocytes on unstimulated peripheral blood lymphocytes to infection with HIV-1. Immunol Letters 35, 83-92 (1993).

20. Kannagi, M. Chalifoux, L. V. & C. I. Lord: Suppression of simian immuno-deficiency virus replication in vitro by CD8-positive lymphocytes. J Immunol 140, 2237-2242 (1988).

21. Kannagi, M. Masuda, T. Hattori, T. Kanoh, T. Nasu, K. Yamamoto, N. & S. Harada: Interference with human immunodeficiency virus (HIV) replication by CD8+T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Virology 64, 3799-3805 (1990).

22. Brinchmann, J. E. Gaudernack, G. & F. Vartdal: CD8+ T -cells inhibit HIV-1 replication in naturally infected CD4+T cells: Evidence for a soluble inhibitor. J Immunol 144, 2961-2966 (1990).

23. Walker, C. M. & J. A. Levy: A diffusible lymphokine produced by CD8-positive T lymphocytes suppresses HIV replication. Immunology 66 628-630 (1989).

24. Walker, C. M. Thomson-Honnebier, G. A. Hsueh, F. C. Erickson, A. L. Pan, L. Z. & J. A. Levy: CD8+ T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 137, 420-428 (1991).

25. J. M. Coffin : Retoviridae: The viruses and their replication. In: Fields Virology, Chapter 58, pp 1767-1847 Lippincott-Raven, Philadelphia (1996).

26 Montelaro, R. C: Vaccines against retroviruses. In " The Retroviridae" vol. 4, Ed: Levy J. A, 605-653, Plenum Press, New York (1995).

27. Hoth, D. F. Bolognesi, D. P. Corey, L. & S. H. Vermund: HIV Vaccine development: A progress report. Ann Int Med 8, 603-611 (1994).

28. Pomerantz, R. J. & D. Trono: Genetic therapies for HIV infections: promise for. the future. AIDS 9, 985-993 (1995).

29. Wei, X. Ghosh, S. K. Taylor, M. E. Johnson, V. A Emini, E. A. Deutsch, P. Lifson, J. D. Bonhoeffer, S. Nowak, M. A. & B. H. Hahn : Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-126 (1995).

30. Fauci, A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239, 617-620 (1988).

31. Bagasra, O. Farzadegan, H. Seshamma, T. Oakes, J. W. Saah, A. & R. J. Pomerantz: Detection of human immunodeficiency virus type 1 in mononuclear cells by in situ polymerase chain reaction. New Eng J Med 326,1385-1391(1992).

32. Bagasra, O. & R. J. Pomerantz: HIV-1 provirus is demonstrated in peripheral blood monocytes in vivo: A study utilizing an in situ PCR. AIDS Res Hum Retroviruses 9:69-76, 1993

33. Patterson, B. K. Till, M. Otto, P. Goolsby, C. Furtado, M. R. McBride, L. J. & S. M. Wolinsky: Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260, 976-980 (1993).

34. Embretson, J. Zupancic, M. Beneke, J. Till, M. Wolinsky, S. Ribas, J. L. Burke, A. & A. T. Haase: Analysis of human immunodeficiency virus-infected tissues by amplification and in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc Natl Acad Sci USA. 90, 357-361 (1993).

35. Embretson, J. Zupancic, M. Ribas, J. L. Burke, A. Racz, P. Tenner-Racz, K. & A. T. Haase: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-62 (1993).

36. Pantaleo, G. Graziosi, C. Demarest, J. F. Cohen, O. J. Vaccarezza, M. Gantt, K. Muro-Cacho, C. & A. S. Fauci : HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-8 (1993).

37. Jeng, C. R. English, R. V. Childers, T. Tompkins, M. B. & W. A. Tompkins: Evidence for CD8+ antiviral activity in cats infected with Feline immunodeficiency virus. J Virol 2474-2480 (1996).

38. Putkonen, P. Walther, L. Zhang, Y. J. Li, S. L. Nilsson, C. Albert, J. Biberfeld, P. Thorstensson, R. & G. Biberfeld: Long-term protection against SIV-induced disease in macaque vaccinated with a live attenuated HIV-2 vaccine. Nature Med 1, 914-918 (1995).

39. Travers, K. Mboup, S. Marlink, R. Gueye-Nidaye, A. Siby, T. Thior, I. Traore, I. Dieng-Sarr, A. Sankale, J. L. & C. Mullins : Natural protection against HIV-1 infection provided by HIV-2. Science 268,1612-15 (1995).

40. Bonhoeffer, S. & M. Nowak: Can live attenuated virus work as post-exposure treatment. Immunol Today 16, 131-34 (1995).

41. Baba, T. W. Gong, Y. S. Pennick, D. Bronson, R. Greene, M. F. & R. M. Ruprecht: Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-25 (1995).

42. Shibata, R. Seimon, C. Cho, M. W. Arthur, L. O. Nigida, S. M. Jr. Matthews. T.Sawyer, L. A. Schultz, A. Murthy, K. K. Israel, Z. Javadian, A. Frost, P.Kennedy, R. C. Lane, H. C. & M. A. Martin: Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of HIV-1. J Virol 70(7), 4361-69 (1996).

43. Putkonen, P. Thorstensson, R. Albert, J. Hild, K. Norrby, E. Biberfeld, P. & G. Biberfeld: Infection of cynomolgus monkey with HIV-2 protects against protects against pathogenic consequences of a subsequent simian immunodeficiency virus infection. AIDS 4, 783-789 (1990).

44. Doranz, B. J. Rucker, J. Yi, Y. Smyth, R. J. Samson, M. Peiper, S. C. Parmentier, M. Collman, R. G. & R. W. Doms: A dual tropic primary HIV-1 isolate that uses Fusin and beta-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusion cofactors. Cell 85, 1149-1158 (1996).

45. Dragic, T. Litwin, V. Allaway, G. P. Martin, S. R. Huang, Y. Nagashima, K. A. Cayanan, C. Maddon, P. J. Koup, R. A. Moore, J. P. & W. A. Paxton: HIV-1 entry into CD4 cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 667-673 (1996).

46. Feng, Y. Broder, C.C. Kennedy, P. E. & E. A. Berger : HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor. Science 272, 872-877 (1996).

47. Neote, K. DiGregorio, D. Mak, J. Y. Horuk, R. & T. J. Schall: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72, 415-425 (1993).

48. Siegel, F. Kurth, R. & S. Norley: Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host. J AIDS 8, 217-26 (1995).

49. Gardner, M. Rosenthal, A. Jennings, M. Yee, J. Antipa, L. & E. Robinson Jr: Passive immunization of Rhesus macaques against SIV infection and disease: Partial protection with plasma from vaccinated monkey and possible enhancement with plasma from healthy carrier, AIDS Res Hum Retroviruses 11,(7), 843-54 (1995).

50. Girard, M. P. & J. W. Eichberg: Progress in the development of SIV vaccines. AIDS 4, S143 (1990).

51. Karzon, D. T. Bolognesi, D. P. & W. C. Koff: Development of a vaccine for the prevention of AIDS, a critical appraisal. Vaccine 10, 1039 (1992).

52. Kent, K. A. Kitchin, P. Mills, K. H. Page, M. Taffs, F. Corcoran, T. Silvera, P. Flanagan, B. Powell, C. & J. Rose: Passive immunization of cynomolgus macaque with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251. AIDS Res Hum Retroviruses 10,189-194 (1994).

53. Orentas, R. J. Hildreth, J. E. Obah, E. Polydefkis, M. Smith, G. E. Clements, M. L. & R. F. Siliciano: Induction of CD4+ human cytolytic T cell-specific for HlV-infected cell by a gpl60 subunit vaccine. Science 248, 1234 (1990).

54. Ruprecht, R. M. Mullaney, S. Bernard, L. D. GamaSosa, M. A. Hom, R. C. & R. W. Finberg : Vaccination with a live retrovirus: The nature of the protective immune response. Proc Natl Acad Sci USA 87, 5558-62 (1990).

55. Alter, H. J. Eichberg, J. W. Masur, H. Saxinger, W. C. Gallo, R. Macher, A.M. Lane, H. C. & A. S. Fauci : Transmission of HTLV-III infection from human plasma to chimpanzees an animal model of AID. Science 226, 549-52 (1984).

56. Francis, D. P. Feorino, P.M. Broderson, J. R. McClure, H. M. Getchell, J. P.

McGrath, C. R. Swenson, B. McDougal, J. S. Palmer, E. L. & A. K. Harrison: Infection of chimpanzees with lymphadenopathy associated virus. Lancet 2,1276-7(1984).

57. Berman, P. W. Gregory, T. Crase, D. & L. A. Lasky: Protection of chimpanzees from infection by HlV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. Nature 345, 622-625 (1990).

58. Heeney, J. Jonker, R. Koornstra, W. Dubbes, R. Niphuis, H. DiRienzo, A. M. Gougeon, M. L. & L. Montagnier: The resistance of HlV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol 22, 194-200 (1993).

59. Eichberg, J. W. Zarling, J. M. Alter, H. J. Levy, J. A. Berman, P. W. Gregory, T. Lasky, L. A. McClure, J. Cobb, K. E. & P. A. Moran: T-cell responses to human Immunodeficiency virus (HIV) and its recombinant antigens in HIV- infected chimpanzees. J Virol 61, 3804-8 (1987).

60. Berman, P.W. Eastman, D. J. Wilkes, D. M. Nakamura, G. R. Gregory, T. J. Schwartz, D. Gorse, G. Belshe, R. Clements, M. L. & R. A. Byrn: Comparison of the immune response to recombinant gp120 in humans and chimpanzees. AIDS 8, (5) 591-601 (1994).

61. Girard, M. Kieny, M. P. Pinter, A. Barre-Sinoussi, F. Nara, P. Kolbe, H. Kusumi, K. Chaput, A. Reinhart, T. & E. Muchmore: Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88, 542-546 (1991).

62. Moore, J. P. Cao, Y. Leu, J. Qin, L. Korber, B. & D. D. Ho: Inter and intraclade neutralization of human immunodeficiency virus type 1: genetic clads do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virology 70, 427-444 (1996).

63. Trkola, A. Pomales, A.B. Yuan, H. Korber, B. Maddon, P.J. Allaway, G.P. Katinger, H. Barbas, C.F 3rd. Burton, D.R. & D. D. Ho: Cross-clad neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virology 69,1586-96 (1995).

64. Girard, M.: Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain. J Virology 70, 8229-33 (1996).

65. Mascola, J. R. Mathieson, B. J. Zack, P. M. Walker, M. C. Halstead, S. B. & D. S. Burke: Summary Report: Workshop on potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res and Human Retroviruses. 9, 1175-84 (1993).

66. Salk, J. Bretscher, P. A. Salk, P. L. Clerici, M. & G. M. Shearer: A strategy for prophylactic vaccination against HIV. Science 260,1270-72 (1993).

67. Clerici, M. & G. M.Shearer: A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14, 107-111(1993).

68. Romagnani, S. Del Prete, G. Manetti, R. Ravina, A. Annunziato, F. De Carli, M. Mazzetti, M. Piccinni, M. P. D'Elios, M. M. & P. Parronchi: Role of Th1/Th2 cytokines in HIV infection. Immun Rev 140, 73-94 (1994 ).

69. Phillips, A. N: Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271, 497-499 (1996).

70. Matteucci, D. Pistello, M. Mazzetti, P. Giannecchini, S. Del Mauro, D. Zaccaro, L. Bandecchi, P. Tozzini, F. & M. Bendinelli: Vaccination protects against in vivo-grown feline immunofecifiency virus even in the absence of detectable neutralization antibodies. J Virology 70, 617-622 (1996).

71. SanMiguel, P. Tikhonov, A. Jin, Y. K. Motchoulskaia, N. Zakharov, D. Melake-Berhan, A. Springer, P.S. Edwards, K.J. Lee, M. Avramova, Z. & J. L. Bennetzen: Nested retrotransposons in the intergenic regions of the maize genome. Science 274, 765-768 (1996).

72. Martin, M. A. Bryan, T. Rasheed, S. & A. S. Khan: Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci USA 78,4892-4899 (1981).

73. Horwitz, M.S. Boyce-Jacino, M.T. & A. J. Faras : Novel human endogenous sequences related to human immunodeficiency virus type 1. J Virol 66, 2170-2179 (1992).

74. Koup, R. A. Safrit, J. T. Cao, Y. Andrews, C. A. McLeod, G. Borkowsky, W. Farthing, C. & D. D. Ho: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68, 4650-55 (1994).

75. Luzuriaga, K. McQuilken, P. Alimenti, A. Somasundaran, M. Hesselton, R. & J. L. Sullivan, J.L: Early viremia and immune responses in vertical human immunodeficiency virus type 1 infection. J Infect Diseases 167, 1008-13 (1993).

76. Jurriaana, S. Van Gemen, B. Weverling, G.J. Van Strijp, D. Nara, P. Coutinho, R. Koot, M. Schuitemaker, H. & J. Goudsmit: The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course. J Clin Invest 204, 223-233 (1994).

77. Borrow, P. Lewicki, H. Wei, X. Horwitz, M. S. Peffer, N. Meyers, H. Nelson, J. A. Gairin, JE. Hahn, B.H. Oldstone, M.B. & G. M. Shaw : Virus specific CD8+ cytotoxic T-lymphocytes activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68, 6103-6110 (1994).

78. Wainberg, M.A, Blain, N. & L. Fitz-Gibbon: Differential susceptibility of human lymphocyte cultures to infection by HIV. Clin Exp Immunol 136-142 (1987).

79. Spira, A. & D.D.Ho: Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. J Virology 69, 422-429 (1995).

80. Pan, L. Z. Sheppard, H. W. Winkelstein, W. & J. A. Levy: Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection. J Infect Dis 164, 962-4 (1991).

81. Soriano, V. & I. Hewlett: Silent HIV infection in heterosexual partners of seropositive drug abusers in Spain. Lancet 335, 860 (1990).

82 Rowland-Jones, S. Sutton, J. Ariyoshi, K. Dong, T. Gotch, F. McAdam, S. Whitby, D. Sabally, S. Gallimore, A. & T. Corrah: HIV-1-specific cytotoxic T-cell in an HIV-exposed but uninfected infant. Lancet 341, 860-861 (1995). Nature Med 1(1), 59-64 (1995).

83 Deacon, N.J. Tsykin, A. Solomon, A. Smith, K. Ludford-Menting, M. Hooker, D.J. McPhee, D.A. Greenway, A.L. Ellett, A. & C. Chatfield: Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-91 (1995).

84. Bryson, Y. J. Pang, S. Wei, L. S. Dickover, R. Diagne, A. & I. S. Chen: Clearance of HIV infection in a perinatally infected infant. New Engl J Med 332, 833-838 (1995).

85. Roques, P.A. Gras, G. Parnet-Mathieu, F. Mabondzo, A.M. Dollfus, C. Narwa, R. Marce, D. Tranchot-Diallo, J. Herve, F. & G. Lasfargues: Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 9: F19-F26 (1995).

86. Baur, A. Schwarz, N. Ellinger, S. Korn, K. Harrer, T. Mang, K. & G. Jahn: Continuous clearance of HIV in a vertically infected child. Lancet 2, 1045 (1989).

87. Kestler, H.W.3rd. Ringler, D.J. Mori, K. Panicali, D.L. Sehgal, P.K. Daniel, M.D. & R. C. Desrosiers: Importance of the nef gene for maintenance of high virus loads and/or development of AIDS. Cell 65, 651-62 (1991).

88. Huang, Y., Zhang, L. & D. D. Ho: Characterization of nef sequences in long term survivors of human immunodeficiency virus type 1 infection. J Virol 69, 93-100 (1995).

89. Saksela, K. Stevens, C. E. Rubinstein, P. Taylor, P. E. & D. Baltimore: Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes. Proc Natl Acad Sci USA 91:1104-8 (1994).

90. Bagnarelli, P. Menzo, S. Valenza, A. Manzin, A. Giacca, M. Ancarani, F. Scalise, G. Varaldo, P. E. & M. Clementi: Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol 66:7328-35 (1992).

91. Almond, N. Kent, K. Cranage, M. Rud, E. Clarke, B. & E. J. Stott: Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345,1342-1344 (1995).

92. Clements, J. E. Montelaro, R. C. Zink, M. C. Amedee, A.M. Miller, S. Trichel, A.M. Jagerski, B. Hauer, D. Martin, L. N. & R. P. Bohm: Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus J Virology 69, 2737-2744 (1995).

93. Daniel, M. D. Kirchhoff, F. Czajak, S. C. Sehgal, P.K.. & R. C. Desrosiers: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941 (1992).

94. Fultz, P.N. Nara, P. Barre-Sinoussi, F. Chaput, A. Greenberg, M. L. Muchmore E. Kieny, M. P. & M. Girard: Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256, 1687-1690, (1992).

95. Heeney, J. L. Holterman, L. ten Haaft, P. Dubbes, R. Koornstra, W. Teeuwsen, V. Bourquin, P. Norley, S. & H. Niphuis: Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res Human Retroviruses 10 (suppl) S117-S121 (1994).

96. Hirsch, V. M. Dapolito, G. A. Goldstein, S. McClure, H. Emau, P. Fultz, P.N. Isahakia, M. Lenroot, R. Myers, G. & P. R. Johnson : A distinct African lentivirus from Sykes' monkeys. J Virol 67, 1517-1528 (1993).

97. Muller, M. C. Saksena, N. K. Nerrienet, E. Chappey, C. Herve, V. M. Durand, J. P. Legal-Campodonico, P. Lang, M. C. Digoutte, J. P. & A. J. Georges: Simian immunodeficiency viruses from Central and Western Africa: Evidence for a new species-specific lentivirus in Tantalus monkeys. J Virol 67, 1227-1235 (1993).

98. Ohta, Y. Masuda, T. Tsujimoto, H. Ishikawa, K. Kodama, T. Morikawa, S. Nakai, M. Honjo, S. & M. Hayami : Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non human primates. Int J Cancer 41, 115-122 (1988).

99. Fultz, P.N. McClure, H. M. Anderson, D. C. Swenson, R. B. Anand, R. & A. Srinivasan: Isolation of a T-lymphocyte retrovirus from naturally infected sooty mangabey monkeys. Proc Natl Acad Sci USA 83, 5286-5290 (1989).

100. Gao, F. Yue, L. White, A. T. Pappas, P. G. Barchue, J. Hanson, A. P. Greene, B. M.Sharp, P.M. Shaw, G. M. & B. H. : Human infection by genetically diverse SlVsm-related HIV-2 in West Africa. Nature 358, 495-499 (1992).

101. Huet, T. Cheynier, R. Meyerhans, Roelants, A. G. & S. Wain-Hobson : Genetic organization of a chimpanzee lentivirus related to HIV-I. Nature 345, 356-358 (1994).

102. Peeters, M. Honore C. Huet T. Bedjabaga L. Ossari S. Bussi P. Cooper R. W. & E. Delaporte: Isolation and partial characterization of an HlV-related virus occurring naturally in chimpanzees in Gabon. AIDS 3, 625- 630 (1989).

103. Francis, D. Ferino, P. Broderson, J. McClure, H. Getchell, J. McCrath, C. Swenson, B. McDougal, J. Palmer, E. Harrison, A. Barre-Sinoussi, F. Chermann, J-C. Montagnier, L. Curran, J. Cabradilla, C. & V. Kalyanaraman: Infection of chimpanzees with lymphadenopathy-associated virus. Lancet ii, 127G-1277 (1984).

104. Gadjusek, D. Gibbs, C. Rodgers-Johnson, P. Amyx, H. Asher, D. Epstein, L. Sarin, P. Gallo, R. Maluish, A. Arthru, L, Montagnier, L. & D. Mildvan: Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissue from AIDS patients. Lancet i, 55-56 (1985).

105. Nara, P. Hatch, W. Kessler, J. & S. Carter: The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations. J. Med. Primatol. 18, 343-55 (1989).

106. Eichberg, J. W. Zarling, J. M. Alter, H. J. Levy, J. A. Berman, P. W. Gregory, T. Lasky, L. A. McClure, J. Cobb, K. E. & P. A. Moran: T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. J Virol 61, 3804-3808 (1987 ).

107. Zarling, J. Alter, H. J. Eichberg, J. W. Fauci, A. S., Robey, W. G. & R. C. Gallo: Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J Immunol 139, 988-990 (1987).

108. Weiss, R. A : Foamy retroviruses: A virus in search of a disease. Nature 333, 497-498 (1988).

109. Mergia, A. & P. A. Luciw: Replication and regulation of primate foamy viruses. Virology 184, 475-482 (1991).

110. K. Sugamura & Y. Hinuma: Human retroviruses: HTLV-I and HTLV-II. In: The Retroviridae. Ed: Levy J. A. p399-435, Plenum Press, New York and London (1992).

111. Utz, U. Banks, D. Jacobson, S. & W. E. Biddison: Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: Evidence of oligoclonal expansion. J Virol 70, 843-851 (1996).

112. Kestens, L. Vingerhoets, J. Peeters, M. Vanham , G. Vereecken , C. Penne, G. Niphuis, H. van Eerd, P. van der Groen, G. & P. Gigase: Phenotypic and functional parameters of cellular immunity in chimpanzee with a naturally acquired simian immunodeficiency virus infection. J Inf Dis 172, 957-63 (1995).

113. Copeland, K. F. McKay, P. J. & K. L. Rosenthal: Suppression of the human immunodeficiency virus long terminal repeat by CD8+ T cells is dependent on the NFAT-1 element. AIDS RES & Human Retroviruses 12, 143-147 (1996).

114. Bouscarat, F. Descamps, V. Cadot, B. & S. Belaich: Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res & Human Retroviruses 12, 17-24 (1996).

115. Yasutomi, Y. Reimann, K. A. Lord, C. I. Miller, M. D. & N. L. Letvin: Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected Rhesus monkeys. J Virol 67, 1707-11 (1993).

116. Sonza, S. Maerz, A. Deacon, N. Meanger, J. Mills, J. & S. Crowe: Human immunodeficiency virus type-1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J Virol 70(6), 3863-3869 (1996).

117. Paxton, W. A. Martin, S. R. Tse, D. O'Brien, T. R. Skurnick, J. VanDevanter, N. L. Padian, N. Braun, J. F. Kotler, D. P. Wolinsky, S. M. & R. A. Koup: Relative resistance to HIV-1 infection of CD4 lymphocytes from person who remain uninfected despite multiple high-risk sexual exposure. Nature Med 2, 412-417 (1996).

118. O. Bagasra, & R. J. Pomerantz: Do alcohol and other substance of abuse alter the natural evolution of and the susceptibility to human immunodeficiency virus type-1 infection? In: "Alcohol, Drugs of abuse, and Immune Function" Ed: Watson, R. CRC Press Inc, New York, (1995).

119. Avins, A. L. Woods, W. J. Lindan, C. P. Hudes, E. S. Clark, W. & S. B. Hulley: HIV infection and risk behaviors among heterosexuals in alcohol treatment programs. JAMA 7, 515-18 (1994).

120. Fong, I. W. Read, S. Wainberg, M. A. Chia, W. K. & C. Major: Alcoholism and rapid progression to AIDS after seroconversion. Clin Infect Dis 19, 337-8, 1994

121. Mahler, J. Yi, D. & M. Sacks: Undetected HIV infection among patients admitted to an alcohol rehabilitation unit. Am J Psychiatry 151, 439-40 (1994).

122. Bagasra, O. Kajdacsy-Balla, A. & H. W. Lischner: Effects of alcohol ingestion on in vitro susceptibility of peripheral blood mononuclear cells to infection with HIV-1 and on selected T-cell functions. Alcoholism: Clin & Expt Res 13, 636-43 (1987).

123. Bagasra, O. Kajdacsy-Balla, A. Lischner, H. W. & R. J. Pomerantz: Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Diseases 16, 789-97 (1993).

124. Bagasra, O. & R. J. Pomerantz: Increased HIV-1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Diseases 168, 1157-64 (1993).

125. Peterson, P. K. Sharp, B. M. Gekker, G. Portoghese, P. S. Sannerud, K. & H. H. Balfour, Jr.: Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell co-cultures. AIDS 4, 869-73 (1990).

126. Chaisson, R. E. Bacchetti, P. Osmond, D. Brodie, B. Sande, M. A. & A. R. Moss: Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 261, 561-51 (1989).

127. Watson, E. S. Murphy, J. C. ElSohly, H. N. ElSohly, M. A. & C. E. Turner: Effects of the administration of coca alkaloids on the primary immune response of mice: interaction with delta-9-tetrahydrocannabinol and ethanol. Toxicol Appl Pharmacol 71,1-16 (1983).

128. Kirchhoff, F. Greenough, T. C. Brettler, D. B. Sullivan, J. L. & R. C. Desrosiers: Brief report: Absence of intact nef sequences in a long term survivor with non progressive HIV-1 infection. N Engl J Med 332, 228-32 (1995).

129. Zack, J. A: HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile latent virus structure. Cell 61, 215-222 (1990).

130. Bukrinsky, M. I. Stanwick, T. L. Dempsey, M. P. & M. Stevenson: Quiescent T-lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427 (1991).

131. Barker, E. Mackewicz, C. E. & J. A. Levy: Effects of Th1 and Th2 cytokines on CD8+ cell response against human immunodeficiency virus: Implications for long-term survival. Proc Natl Acad Sci USA 92,11135-39 (1995).

132. Bagasra, O. Howeedy, A. & R. J. Pomerantz: Functional analysis of T-cell subsets in chronic alcoholism. Immunology 61, 63-9 (1987).

133. Bagasra, O. Bachman, S. E. Jew, L. Tawadros, R. Cater, J. Boden, G. Ryan, I. & R. J. Pomerantz: Increased HIV-1 replication in human peripheral blood mononuclear cells induced by ethanol: Potential immuno-pathologic mechanisms. J Infect Diseases 173, 550-558 (1996).